BACKGROUND: Ethanol modulates glutamate and γ-aminobutyric (GABA) function. However, little is known about the acute pharmacologic effects of ethanol on levels of GABA, glutamate, and other metabolites measurable in the human cortex in vivo with proton magnetic resonance spectroscopy ((1)H-MRS). METHODS: Eleven healthy social drinkers received two intravenous ethanol infusions that raised breath alcohol levels to a clamped plateau of 60 mg/dL over 60-70 min. The first infusion established tolerability of the procedure, and the second procedure, conducted 15 ± 12 days later, was performed during (1)H-MRS of occipital GABA, glutamate, and other metabolites. RESULTS: The time course of brain ethanol approximated that of breath ethanol, but venous ethanol lagged by approximately 7 min. The GABA fell 13 ± 8% after 5 min of the ethanol infusion and remained reduced (p = .003) throughout the measurement. The combination of N-acetylaspartate and N-acetylaspartyl glutamate (summed as NAA) fell steadily during the infusion by 8 ± 3% (p = .0036). CONCLUSIONS: Ethanol reduced cortical GABA and NAA levels in humans. Reductions in GABA levels are consistent with facilitation of GABA(A) receptor function by ethanol. The gradual decline in NAA levels suggests inhibition of neural or metabolic activity in the brain.
BACKGROUND:Ethanol modulates glutamate and γ-aminobutyric (GABA) function. However, little is known about the acute pharmacologic effects of ethanol on levels of GABA, glutamate, and other metabolites measurable in the human cortex in vivo with proton magnetic resonance spectroscopy ((1)H-MRS). METHODS: Eleven healthy social drinkers received two intravenous ethanol infusions that raised breath alcohol levels to a clamped plateau of 60 mg/dL over 60-70 min. The first infusion established tolerability of the procedure, and the second procedure, conducted 15 ± 12 days later, was performed during (1)H-MRS of occipital GABA, glutamate, and other metabolites. RESULTS: The time course of brain ethanol approximated that of breath ethanol, but venous ethanol lagged by approximately 7 min. The GABA fell 13 ± 8% after 5 min of the ethanol infusion and remained reduced (p = .003) throughout the measurement. The combination of N-acetylaspartate and N-acetylaspartyl glutamate (summed as NAA) fell steadily during the infusion by 8 ± 3% (p = .0036). CONCLUSIONS:Ethanol reduced cortical GABA and NAA levels in humans. Reductions in GABA levels are consistent with facilitation of GABA(A) receptor function by ethanol. The gradual decline in NAA levels suggests inhibition of neural or metabolic activity in the brain.
Authors: J H Krystal; I L Petrakis; E Webb; N L Cooney; L P Karper; S Namanworth; P Stetson; L A Trevisan; D S Charney Journal: Arch Gen Psychiatry Date: 1998-04
Authors: M Bendszus; H G Weijers; G Wiesbeck; M Warmuth-Metz; A J Bartsch; S Engels; J Böning; L Solymosi Journal: AJNR Am J Neuroradiol Date: 2001 Nov-Dec Impact factor: 3.825
Authors: K L Behar; D L Rothman; K F Petersen; M Hooten; R Delaney; O A Petroff; G I Shulman; V Navarro; I L Petrakis; D S Charney; J H Krystal Journal: Am J Psychiatry Date: 1999-06 Impact factor: 18.112
Authors: Natalie M Zahr; Dirk Mayer; Torsten Rohlfing; Michael P Hasak; Oliver Hsu; Shara Vinco; Juan Orduna; Richard Luong; Edith V Sullivan; Adolf Pfefferbaum Journal: Biol Psychiatry Date: 2009-12-30 Impact factor: 13.382
Authors: Joshua L Gowin; Matthew E Sloan; Bethany L Stangl; Vatsalya Vatsalya; Vijay A Ramchandani Journal: Am J Psychiatry Date: 2017-08-04 Impact factor: 18.112
Authors: Christian Sommer; Christian Seipt; Maik Spreer; Toni Blümke; Alexandra Markovic; Elisabeth Jünger; Martin H Plawecki; Ulrich S Zimmermann Journal: Alcohol Clin Exp Res Date: 2015-04-23 Impact factor: 3.455
Authors: James J Prisciandaro; Joseph P Schacht; Andrew P Prescot; Perry F Renshaw; Truman R Brown; Raymond F Anton Journal: Alcohol Clin Exp Res Date: 2019-01-04 Impact factor: 3.455
Authors: James J Prisciandaro; Joseph P Schacht; Andrew P Prescot; Helena M Brenner; Perry F Renshaw; Truman R Brown; Raymond F Anton Journal: Addict Biol Date: 2019-08-01 Impact factor: 4.280
Authors: Marisa M Silveri; Jennifer T Sneider; David J Crowley; Michael J Covell; Deepa Acharya; Isabelle M Rosso; J Eric Jensen Journal: Biol Psychiatry Date: 2013-03-14 Impact factor: 13.382